Literature DB >> 16937428

Slow transit constipation: a functional disorder becomes an enteric neuropathy.

Gabrio Bassotti, Vincenzo Villanacci.   

Abstract

Slow transit constipation has been traditionally considered and classified as a functional disorder. However, clinical and manometric evidence has been accumulating that suggests how most of the motility alterations in STC might be considered of neuropathic type. In addition, further investigations showed that subtle alterations of the enteric nervous system, not evident to conventional histological examination, may be present in these patients. In the present article we will discuss these evidences, and will try to put them in relation with the abnormal motor function of the large bowel documented in this pathological condition.

Entities:  

Mesh:

Year:  2006        PMID: 16937428      PMCID: PMC4087822          DOI: 10.3748/wjg.v12.i29.4609

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  81 in total

Review 1.  Idiopathic slow-transit constipation.

Authors:  A MacDonald; J N Baxter; I G Finlay
Journal:  Br J Surg       Date:  1993-09       Impact factor: 6.939

2.  Severe slow-transit constipation following radical hysterectomy.

Authors:  M E Vierhout; H W Schreuder; H F Veen
Journal:  Gynecol Oncol       Date:  1993-12       Impact factor: 5.482

3.  Disturbed gastric and small bowel transit in severe idiopathic constipation.

Authors:  J R van der Sijp; M A Kamm; J M Nightingale; K E Britton; M Granowska; S J Mather; L M Akkermans; J E Lennard-Jones
Journal:  Dig Dis Sci       Date:  1993-05       Impact factor: 3.199

4.  Visceral neuropathy in slow transit constipation: an immunohistochemical investigation with monoclonal antibodies against neurofilament.

Authors:  W R Schouten; F J ten Kate; E J de Graaf; E C Gilberts; J L Simons; P Klück
Journal:  Dis Colon Rectum       Date:  1993-12       Impact factor: 4.585

5.  Detection of subclinical autonomic neuropathy in constipated patients using a sweat test.

Authors:  D Altomare; M A Pilot; M Scott; N Williams; M Rubino; L Ilincic; D Waldron
Journal:  Gut       Date:  1992-11       Impact factor: 23.059

6.  Mutation of the proto-oncogene c-kit blocks development of interstitial cells and electrical rhythmicity in murine intestine.

Authors:  S M Ward; A J Burns; S Torihashi; K M Sanders
Journal:  J Physiol       Date:  1994-10-01       Impact factor: 5.182

7.  Motor abnormalities in the terminal ileum of patients with chronic idiopathic constipation.

Authors:  B Panagamuwa; D Kumar; J Ortiz; M R Keighley
Journal:  Br J Surg       Date:  1994-11       Impact factor: 6.939

8.  Observations on the characteristics of stimulated defaecation in severe idiopathic constipation.

Authors:  M A Kamm; J R van der Sijp; J E Lennard-Jones
Journal:  Int J Colorectal Dis       Date:  1992-12       Impact factor: 2.571

9.  W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity.

Authors:  J D Huizinga; L Thuneberg; M Klüppel; J Malysz; H B Mikkelsen; A Bernstein
Journal:  Nature       Date:  1995-01-26       Impact factor: 49.962

10.  Impaired colonic motor response to cholinergic stimulation in patients with severe chronic idiopathic (slow transit type) constipation.

Authors:  G Bassotti; G Chiarioni; B P Imbimbo; C Betti; F Bonfante; I Vantini; A Morelli; W E Whitehead
Journal:  Dig Dis Sci       Date:  1993-06       Impact factor: 3.199

View more
  28 in total

1.  The role of hand-assisted laparoscopic surgery in total colectomy for colonic inertia: a retrospective study.

Authors:  Dan Yang Wang; Jian Jiang Lin; Xiang Ming Xu; Fan Long Liu
Journal:  J Korean Surg Soc       Date:  2013-08-26

2.  β-nicotinamide adenine dinucleotide is an enteric inhibitory neurotransmitter in human and nonhuman primate colons.

Authors:  Sung Jin Hwang; Leonie Durnin; Laura Dwyer; Poong-Lyul Rhee; Sean M Ward; Sang Don Koh; Kenton M Sanders; Violeta N Mutafova-Yambolieva
Journal:  Gastroenterology       Date:  2010-09-25       Impact factor: 22.682

3.  Effects of nociceptin/orphanin FQ on rats with cathartic colon.

Authors:  Hai-Yan Li; Xiang Yan; Quan-Lai Xue; Yong-Ning Zhou; Yan Gao; Rui Wang; Yong-Ming Liu; Jun-Tao Ran
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

4.  Motility: prucalopride for chronic constipation.

Authors:  Gabrio Bassotti; Vincenzo Villanacci
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-06       Impact factor: 46.802

5.  The use of prucalopride in real life for the treatment of constipation subtypes: ups and downs.

Authors:  G Bassotti; M Bellini
Journal:  Tech Coloproctol       Date:  2013-05-24       Impact factor: 3.781

6.  Mast cells in intestinal motility disorders: please also look beyond IBS….

Authors:  Gabrio Bassotti; Vincenzo Villanacci
Journal:  Dig Dis Sci       Date:  2012-07-31       Impact factor: 3.199

Review 7.  Beyond hematoxylin and eosin: the importance of immunohistochemical techniques for evaluating surgically resected constipated patients.

Authors:  G Bassotti; V Villanacci; B Salerni; C A Maurer; G Cathomas
Journal:  Tech Coloproctol       Date:  2011-07-16       Impact factor: 3.781

Review 8.  A practical approach to diagnosis and management of functional constipation in adults.

Authors:  Gabrio Bassotti; Vincenzo Villanacci
Journal:  Intern Emerg Med       Date:  2011-10-02       Impact factor: 3.397

9.  Sacral nerve stimulation with appropriate parameters improves constipation in rats by enhancing colon motility mediated via the autonomic-cholinergic mechanisms.

Authors:  Zhihui Huang; Shiying Li; Robert D Foreman; Jieyun Yin; Ning Dai; Jiande D Z Chen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-08-14       Impact factor: 4.052

10.  Cellular and molecular basis of chronic constipation: taking the functional/idiopathic label out.

Authors:  Gabrio Bassotti; Vincenzo Villanacci; Dragos Creţoiu; Sanda Maria Creţoiu; Gabriel Becheanu
Journal:  World J Gastroenterol       Date:  2013-07-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.